Hyperlipoproteinemia, Type V

Description

A severe type of hyperlipidemia, sometimes familial, that is characterized by the elevation of both plasma CHYLOMICRONS and TRIGLYCERIDES contained in VERY-LOW-DENSITY LIPOPROTEINS. Type V hyperlipoproteinemia is often associated with DIABETES MELLITUS and is not caused by reduced LIPOPROTEIN LIPASE activity as in HYPERLIPOPROTEINEMIA TYPE I .

Genes related to Hyperlipoproteinemia, Type V

CREB3L3
APOA5
LPL

Clinical Features

Phenotypes and symptoms related to Hyperlipoproteinemia, Type V

Decreased HDL cholesterol concentration
Decreased LDL cholesterol concentration
Increased VLDL cholesterol concentration
Increased circulating chylomicron concentration

Incidence and onset information

— Not enough data available about incidence and published cases.

Accelerate your rare disease diagnosis with us

Learn more

Hyperlipoproteinemia, Type V Recommended genes panels

Panel Name, Specifity and genes Tested/covered
CREB3L3. By Institute for Human Genetics University Clinic Freiburg in Germany. CREB3L3 Specificity 100 % Genes 34 %
Comprehensive Cardiology Sequencing Panel with CNV Detection. By PreventionGenetics PreventionGenetics in United States. HFE, TTR, GAA, COL3A1, ELN, EYA4, JAG1, DSP, SLC25A4, CRYAB, HADHA, RAF1, FBN1, GCKR, DNAJC19, SCO2, TAZ, COX15, CBS, ALMS1 , (...) View the complete list with 144 more genes Panel GTR000553680 complete gene list HFE, TTR, GAA, COL3A1, ELN, EYA4, JAG1, DSP, SLC25A4, CRYAB, HADHA, RAF1, FBN1, GCKR, DNAJC19, SCO2, TAZ, COX15, CBS, ALMS1, COL5A2, DOLK, BRAF, DMD, GLA, HRAS, KRAS, LDLR, MAP2K1, NRAS, PTPN11, SHOC2, SOS1, MAP2K2, CBL, SMAD4, PRKAR1A, FKTN, SGCG, HSPB8, LMNA, APOE, FKRP, CAV3, TTN, DES, MYH7, LDB3, BAG3, FHL1, SELENON, RYR1, MYBPC3, ACTA1, TMEM43, EMD, TCAP, SGCD, KCNJ2, KCND3, LAMA2, KCNH2, SCN1B, HCN4, SCN5A, CACNA2D1, MYO6, KCNE1, KCNQ1, CACNA1C, LAMP2, NODAL, TGFB2, NOTCH1, SMAD3, TGFBR2, MYLK, FBN2, ACTA2, SLC2A10, MYH11, TRPM4, KCNJ8, ABCC9, SCN2B, SCN3B, KCNE3, CACNB2, GPD1L, PKP2, ANK2, RYR2, CALM1, TRDN, KCNE2, KCNJ5, SNTA1, CASQ2, AKAP9, SCN4B, LTBP2, EFEMP2, KCNA5, PDLIM3, ILK, ACTC1, MYLK2, TGFB3, LAMA4, PRDM16, NKX2-5, ANKRD1, TNNC1, TNNI3, MYH6, PRKAG2, PLN, NEXN, DSG2, JUP, MYPN, RANGRF, TPM1, TNNT2, GATAD1, JPH2, MYOZ2, RBM20, ACTN2, CSRP3, DSC2, MYL2, MYL3, DTNA, VCL, DPP6, SALL4, TBX5, FHL2, ABCG5, ABCG8, TMPO, ZIC3, CRELD1, CETP, LDLRAP1, APOA5, LPL, LMF1, APOC2, GPIHBP1, NPPA, GJA5, APOA4, CREB3L3, CAVIN4, MIB1, CALR3, TBX3, KLF10, ZHX3, TRIM63, SREBF2, ZBTB17 Specificity 2 % Genes 100 %
MAJOR HYPERTRIGLYCERIDEMIA. By GENETAQ Molecular Genetics Centre and Diagnosis of Rare Diseases in Spain. APOA5, LPL, LMF1, APOC2, GPIHBP1, CREB3L3, LIPI Specificity 43 % Genes 100 %
CREB3L3. By Fulgent Genetics Fulgent Genetics in United States. CREB3L3 Specificity 100 % Genes 34 %
Cholestasis Panel. By Blueprint Genetics in Finland. EPCAM, ABCB11, ABCB4, ATP8B1, TRMU, JAG1, NPHP3, NPHP1, NPHP4, SLC25A13, SMPD1, DGUOK, FAH, MKS1, CFTR, NPC1, NPC2, PEX2, SERPINA1, UGT1A1 , (...) View the complete list with 26 more genes Panel GTR000552643 complete gene list EPCAM, ABCB11, ABCB4, ATP8B1, TRMU, JAG1, NPHP3, NPHP1, NPHP4, SLC25A13, SMPD1, DGUOK, FAH, MKS1, CFTR, NPC1, NPC2, PEX2, SERPINA1, UGT1A1, PEX1, TMEM216, CYP7B1, DCDC2, PEX6, TJP2, PEX26, PEX10, PEX12, PEX5, AKR1D1, LMF1, NEUROG3, VPS33B, VIPAS39, BAAT, ABCC2, TTC37, NOTCH2, HSD3B7, CREB3L3, LCT, SLC26A3, NR1H4, MYO5B, SPINT2 Specificity 3 % Genes 34 %
Hyperlipidemia Panel. By Blueprint Genetics in Finland. ALMS1, LDLR, LIPA, APOE, ABCG5, ABCG8, APOA1, PCSK9, LDLRAP1, APOB, APOA5, LPL, LMF1, APOC2, GPIHBP1, ABCA1, APOC3, CREB3L3 Specificity 17 % Genes 100 %
Hypertriglyceridemias Panel. By Knight Diagnostic Laboratories - Molecular Diagnostic Center Oregon Health & Science University in United States. APOA5, LPL, LMF1, APOC2, GPIHBP1 Specificity 40 % Genes 67 %
APOA5. By Institute for Human Genetics University Clinic Freiburg in Germany. APOA5 Specificity 100 % Genes 34 %
Dyslipidemia NGS panel (29 genes), Sequence & CNV analysis. By Laboratory of genome diagnostics Academic Medical Center, University of Amsterdam in Netherlands. CYP27A1, LDLR, LIPA, MTTP, APOE, ABCG5, ABCG8, CETP, SCARB1, APOA1, PCSK9, LDLRAP1, APOB, APOA5, LPL, LMF1, APOC2, GPIHBP1, ANGPTL3, LCAT , (...) View the complete list with 9 more genes Panel GTR000552854 complete gene list CYP27A1, LDLR, LIPA, MTTP, APOE, ABCG5, ABCG8, CETP, SCARB1, APOA1, PCSK9, LDLRAP1, APOB, APOA5, LPL, LMF1, APOC2, GPIHBP1, ANGPTL3, LCAT, ABCA1, APOC3, LIPC, SLCO1B1, CYP7A1, LIPG, STAP1, MYLIP, SAR1B Specificity 7 % Genes 67 %
APOA5. Complete sequencing. By Instituto de Medicina Genomica Instituto de Medicina Genomica in Spain. APOA5 Specificity 100 % Genes 34 %
Hyperlipoproteinemia type 4 (sequence analysis of APOA5 gene). By CGC Genetics in Portugal. APOA5 Specificity 100 % Genes 34 %
Obesity genetic testing. By CGC Genetics in Portugal. MC4R, GNB3, APOA5, ADRB2, INSIG2, FTO Specificity 17 % Genes 34 %
HYPERLIPOPROTEINEMIA, TYPE V. By Laboratory for Molecular Diagnostics Center for Nephrology and Metabolic Disorders in Germany. APOA5 Specificity 100 % Genes 34 %
Hypertriglyceridemia. By Laboratory for Molecular Diagnostics Center for Nephrology and Metabolic Disorders in Germany. APOA5 Specificity 100 % Genes 34 %
Chylomicronemia. By Laboratory for Molecular Diagnostics Center for Nephrology and Metabolic Disorders in Germany. APOE, APOA5, LPL, APOC2, GPIHBP1 Specificity 40 % Genes 67 %
Type 3 hyperlipoproteinemia. By Unit for Cardiac and Cardiavasular Genetics Oslo University Hospital HF - Ullevaal in Norway. APOA5, LPL, LMF1, APOC2, GPIHBP1 Specificity 40 % Genes 67 %
Single gene testing APOA5. By CeGaT GmbH in Germany. APOA5 Specificity 100 % Genes 34 %
Hyperlipoproteinemia, type 5. By Asper Biogene Asper Biogene LLC in Estonia. APOA5 Specificity 100 % Genes 34 %
Hypertriglyceridemia. By Asper Biogene Asper Biogene LLC in Estonia. GPD1, APOA5, LPL, LMF1, APOC2, GPIHBP1 Specificity 34 % Genes 67 %
Inherited Cardiovascular Diseases and Sudden Death Panel. By Health in Code in Spain. HFE, TTR, AARS2, ACAD9, ACADM, AGL, ACADVL, ATPAF2, GAA, COL1A1, COL1A2, COL3A1, PSEN1, ELN, EYA4, GNPTAB, GLB1, PITX2, JAG1, DSP , (...) View the complete list with 193 more genes Panel GTR000521465 complete gene list HFE, TTR, AARS2, ACAD9, ACADM, AGL, ACADVL, ATPAF2, GAA, COL1A1, COL1A2, COL3A1, PSEN1, ELN, EYA4, GNPTAB, GLB1, PITX2, JAG1, DSP, DLD, SLC25A4, CRYAB, RAF1, FBN1, MTO1, MRPL3, LIAS, AGK, TMEM70, FAH, MRPS22, TSFM, DNAJC19, GFM1, COQ2, PDHA1, TAZ, PHKA1, COX15, SURF1, GUSB, MLYCD, CBS, COX6B1, SLC22A5, PMM2, ALMS1, COL5A1, COL5A2, DOLK, BRAF, DMD, GLA, HRAS, KRAS, LDLR, MAP2K1, NRAS, PLOD1, PTPN11, SHOC2, SOS1, MAP2K2, CBL, SMAD4, ENG, FKTN, SGCA, SGCB, CAPN3, LMNA, PSEN2, NOTCH3, FKRP, CAV3, TTN, DES, MYH7, FLNC, MYOT, LDB3, BSCL2, BAG3, FHL1, MYBPC3, ACTA1, TMEM43, EMD, TCAP, SGCD, KCNJ2, KCND3, LAMA2, KCNH2, SCN1B, HCN4, SCN5A, FLNA, CACNA2D1, TBX1, CACNA1D, KCNE1, KCNQ1, CACNA1C, LAMP2, SPRED1, TGFB2, NOTCH1, SMAD3, TGFBR1, TGFBR2, SKI, MYLK, FBN2, ACTA2, SLC2A10, MYH11, TRPM4, SLMAP, KCNJ8, ABCC9, SCN2B, SCN3B, KCNE3, CACNB2, GPD1L, PKP2, ANK2, RYR2, CALM1, CALM2, TRDN, KCNE2, KCNJ5, SNTA1, CASQ2, AKAP9, SCN4B, ACVRL1, BMPR1B, GDF2, KCNK3, CAV1, SMAD9, KCNA5, BMPR2, PDLIM3, NEBL, ACTC1, MYLK2, TGFB3, LAMA4, PRDM16, NKX2-5, ANKRD1, TNNC1, TNNI3, MYH6, PRKAG2, PLN, NEXN, DSG2, JUP, MYPN, RANGRF, TPM1, TNNT2, GATAD1, JPH2, MYOZ2, RBM20, ACTN2, CSRP3, DSC2, MYL2, MYL3, DTNA, VCL, PRKG1, TBX5, GJA1, CTF1, FHL2, TXNRD2, TMPO, GATA4, CRELD1, CETP, PCSK9, APOB, APOA5, GATA6, NPPA, GJA5, AGPAT2, ANK3, OBSL1, SCN10A, CTNNA3, KCNE5, ADAMTSL4, APOC3, CAVIN4, TBX20, MIB1, CALR3, LRP6, KLF10, TRIM63, SMAD1, FOXD4, FHOD3 Specificity 1 % Genes 34 %
Cardiovascular Diseases_General Panel. By Health in Code in Spain. HFE, TTR, AARS2, ACAD9, AGL, ACADVL, ATP5F1E, ATP7A, ATPAF2, B4GALT7, GAA, HNF1A, NEUROD1, PPARG, COL1A1, COL1A2, COL3A1, ELAC2, PSEN1, HNF1B , (...) View the complete list with 360 more genes Panel GTR000530651 complete gene list HFE, TTR, AARS2, ACAD9, AGL, ACADVL, ATP5F1E, ATP7A, ATPAF2, B4GALT7, GAA, HNF1A, NEUROD1, PPARG, COL1A1, COL1A2, COL3A1, ELAC2, PSEN1, HNF1B, ELN, EYA4, CPT2, WFS1, GNPTAB, GLB1, FOXC1, PITX2, JAG1, NPHP4, PCDH15, DSP, DLD, SLC25A4, GCK, FOXRED1, CRYAB, RAF1, OPA3, FBN1, MTO1, MRPL3, LIAS, GPD1, AGK, DNM1L, TMEM70, FAH, IDH2, CAVIN1, SLC39A13, MRPS22, SLC25A3, PNPLA2, TSFM, DNAJC19, GFM1, MEF2A, COQ2, SCO2, PDHA1, TAZ, PHKA1, COX15, SURF1, GUSB, MLYCD, CBS, PYGM, FXN, COX6B1, SLC22A5, PMM2, ALMS1, ZFHX3, COL5A1, COL5A2, SDHA, DOLK, BRAF, CHD7, CREBBP, DMD, FOXF1, GLA, HRAS, KRAS, LDLR, LEP, LIPA, MAP2K1, NRAS, PLOD1, PTPN11, SHOC2, SOS1, SOS2, RIT1, MAP2K2, CBL, BMPR1A, SMAD4, ENG, ADAMTS2, FKTN, MTTP, SGCA, SGCB, CAPN3, LMNA, PSEN2, APOE, NOTCH3, FKRP, CAV3, NF1, CEL, KCNJ11, INS, PDX1, HNF4A, TTN, DES, MYH7, FLNC, ANO5, MYOT, LDB3, BSCL2, BAG3, FHL1, RYR1, MYBPC3, ACTA1, SYNE1, TMEM43, SYNE2, EMD, TCAP, SGCD, KCNJ2, KCND3, LAMA2, KCNH2, SCN1B, HCN4, SCN5A, FLNA, KMT2D, CACNA2D1, KANSL1, TBX1, CACNA1D, KCNE1, KCNQ1, MED12, FOXP1, EHMT1, CACNA1C, CTNNB1, LZTR1, RASA1, FOXP3, LAMP2, UPF3B, ZDHHC9, SPRED1, RASA2, RRAS, A2ML1, ABCB1, NODAL, FOXH1, TGFB2, NOTCH1, SMAD3, TGFBR1, TGFBR2, SKI, MYLK, FBN2, ACTA2, SLC2A10, MYH11, FKBP14, CHST14, ACVR1, TRPM4, SLMAP, KCNJ8, ABCC9, SCN2B, SCN3B, KCNE3, CACNB2, GPD1L, PKP2, ANK2, RYR2, CALM1, CALM2, TRDN, KCNE2, KCNJ5, SNTA1, CASQ2, AKAP9, SCN4B, ACVRL1, BMPR1B, GDF2, KCNK3, CAV1, SMAD9, EFEMP2, KCNA5, BMPR2, PDLIM3, ILK, NEBL, ACTC1, MYLK2, TGFB3, LAMA4, PRDM16, NKX2-5, ANKRD1, TNNC1, TNNI3, MYH6, PRKAG2, PLN, NEXN, DSG2, JUP, MYPN, RANGRF, TPM1, TNNT2, GATAD1, JPH2, MYOZ2, RBM20, ACTN2, CSRP3, DSC2, MYL2, MYL3, DTNA, AMPD1, TOR1AIP1, SPEG, VCL, ZMPSTE24, PRKG1, MFAP5, NOS1AP, SALL4, TBX5, EP300, GJA1, FHL2, B3GAT3, ABCG5, ABCG8, CYP2D6, OBSCN, TXNRD2, TMPO, ZIC3, GDF1, GATA4, EVC, IER3IP1, NPC1L1, CITED2, LEFTY2, CRELD1, ACVR2B, CETP, SCARB1, APOA1, PCSK9, LDLRAP1, APOB, APOA5, LPL, LMF1, APOC2, GPIHBP1, ANGPTL3, ABCG1, LCAT, ABCA1, SLC2A2, AKT2, RFX6, PAX4, KLF11, BLK, GLIS3, NEUROG3, PTF1A, GATA6, EIF2AK3, PDGFRA, INSR, CFC1, XK, TDGF1, COL7A1, NPPA, GJA5, NOTCH2, TBC1D4, CIDEC, PLIN1, AGPAT2, ZFPM2, ANK3, OBSL1, FGF12, COA5, SCN10A, CTNNA3, KCNE5, ADAMTSL4, GATA5, APOC3, LIPC, PLTP, CHRM2, CAVIN4, SLCO1B1, EIF2AK4, TBX20, MIB1, CALR3, ASPH, CALM3, MYLIP, SAR1B, TFAP2B, SMAD6, TAB2, TNNI3K, CYP3A4, INSIG2, LRP6, PKP4, KLF10, TRIM63, COA6, MED13L, KCND2, MRPL44, NKX2-6, CYP3A5, MCTP2, IRX4, SMAD1, FOXD4, FHOD3, PERP, PPP1R13L, KCNK17, IRX3, SLC22A8, LPA, MYOM1, PPARA, NNT, SLC25A40, HAND2, GREM2, ISL1, TOPBP1, TRIB1, BMP10, CH25H Specificity 1 % Genes 67 %
Dyslipidemias / Early atherosclerosis. By Health in Code in Spain. HNF1A, NEUROD1, PPARG, HNF1B, CPT2, WFS1, PCDH15, GCK, GPD1, CAVIN1, PNPLA2, MEF2A, COQ2, PYGM, LDLR, LEP, LIPA, MTTP, LMNA, APOE , (...) View the complete list with 64 more genes Panel GTR000530656 complete gene list HNF1A, NEUROD1, PPARG, HNF1B, CPT2, WFS1, PCDH15, GCK, GPD1, CAVIN1, PNPLA2, MEF2A, COQ2, PYGM, LDLR, LEP, LIPA, MTTP, LMNA, APOE, CEL, KCNJ11, INS, PDX1, HNF4A, BSCL2, RYR1, FOXP3, ABCB1, CAV1, AMPD1, ZMPSTE24, ABCG5, ABCG8, CYP2D6, IER3IP1, NPC1L1, CETP, SCARB1, APOA1, PCSK9, LDLRAP1, APOB, APOA5, LPL, LMF1, APOC2, GPIHBP1, ANGPTL3, ABCG1, LCAT, ABCA1, SLC2A2, AKT2, RFX6, PAX4, KLF11, BLK, GLIS3, NEUROG3, PTF1A, GATA6, EIF2AK3, INSR, TBC1D4, CIDEC, PLIN1, AGPAT2, APOC3, LIPC, PLTP, SLCO1B1, MYLIP, SAR1B, CYP3A4, INSIG2, LRP6, CYP3A5, SLC22A8, LPA, PPARA, SLC25A40, TRIB1, CH25H Specificity 3 % Genes 67 %
Primary familial hypertriglyceridemias. By Health in Code in Spain. PCDH15, GPD1, PNPLA2, APOE, APOA5, LPL, LMF1, APOC2, GPIHBP1, APOC3, SLC25A40, TRIB1 Specificity 17 % Genes 67 %
Hypertriglyceridaemia genetic screen. By Cardiovascular Genetics Laboratory PathWest Laboratory Medicine WA in Australia. APOE, APOA5, LPL, LMF1, APOC2, GPIHBP1 Specificity 34 % Genes 67 %
Major Hypertriglyceridemia: sequencing of APOA5 gene. By GENETAQ Molecular Genetics Centre and Diagnosis of Rare Diseases in Spain. APOA5 Specificity 100 % Genes 34 %
APOA5. By Fulgent Genetics Fulgent Genetics in United States. APOA5 Specificity 100 % Genes 34 %
Pancreatitis Panel. By Blueprint Genetics in Finland. CFTR, SPINK1, PRSS1, CTRC, APOA5, APOC2, GPIHBP1, CPA1, UBR1 Specificity 12 % Genes 34 %
Familial hypertriglyceridemia. By Bioarray in Spain. APOA5 Specificity 100 % Genes 34 %
Hypertriglyceridemia. By Molecular Diagnostic Laboratory for Inherited Cardiovascular Disease Montreal Heart Institute in Canada. APOA5, LPL, LMF1, APOC2, GPIHBP1 Specificity 40 % Genes 67 %
HYPERLIPOPROTEINEMIA TYPE 5. By Laboratorio de Genetica Clinica SL in Spain. APOA5 Specificity 100 % Genes 34 %
MAJOR HYPERTRIGLYCERIDEMIA. By Laboratorio de Genetica Clinica SL in Spain. APOA5, LPL, LMF1, APOC2, GPIHBP1, LIPI Specificity 34 % Genes 67 %
Major Hypertriglyceridemia, Sequencing APOA5 Gene. By Reference Laboratory Genetics in Spain. APOA5 Specificity 100 % Genes 34 %
Major Hypertriglyceridemia, Panel Massive Sequencing (NGS) 7 Genes. By Reference Laboratory Genetics in Spain. APOE, APOA5, LPL, LMF1, APOC2, GPIHBP1, LIPI Specificity 29 % Genes 67 %
LPL Sequencing. By Cincinnati Children's Hospital Medical Center Laboratory of Genetics and Genomics Cincinnati Children's Hospital Medical Center in United States. LPL Specificity 100 % Genes 34 %
LPL. By Institute for Human Genetics University Clinic Freiburg in Germany. LPL Specificity 100 % Genes 34 %
LPL. Complete sequencing. By Instituto de Medicina Genomica Instituto de Medicina Genomica in Spain. LPL Specificity 100 % Genes 34 %
LPL. Detection of the mutation p.Gly188Glu by sequencing. By Instituto de Medicina Genomica Instituto de Medicina Genomica in Spain. LPL Specificity 100 % Genes 34 %
LPL. MLPA testing. By Instituto de Medicina Genomica Instituto de Medicina Genomica in Spain. LPL Specificity 100 % Genes 34 %
Lipoprotein Lipase De¬ciency (LPL): mutations Pro207Leu (p.Pro234Leu) and Gly188Glu (p.Gly215Glu). By Molecular Diagnostics Laboratory Hospital Sainte-Justine in Canada. LPL Specificity 100 % Genes 34 %
Lipase deficiency (sequence analysis of LPL gene). By CGC Genetics in Portugal. LPL Specificity 100 % Genes 34 %
Lipase deficiency (deletion/duplication analysis of LPL gene). By CGC Genetics in Portugal. LPL Specificity 100 % Genes 34 %
Hyperlipoproteinemia, type I. By Laboratory for Molecular Diagnostics Center for Nephrology and Metabolic Disorders in Germany. LPL Specificity 100 % Genes 34 %
Combined hyperlipidemia, familial. By Laboratory for Molecular Diagnostics Center for Nephrology and Metabolic Disorders in Germany. LPL Specificity 100 % Genes 34 %
Familial Lipoprotein Lipase Deficiency via LPL Gene Sequencing with CNV Detection. By PreventionGenetics PreventionGenetics in United States. LPL Specificity 100 % Genes 34 %
Hyperlipoproteinemia type I. By Centogene AG - the Rare Disease Company in Germany. LPL Specificity 100 % Genes 34 %
Familial Lipoprotein Lipase Deficiency. By bio.logis Center for Human Genetics Diagnosticum in Germany. LPL Specificity 100 % Genes 34 %
Familial Lipoprotein Lipase Deficiency. By Asper Biogene Asper Biogene LLC in Estonia. LPL Specificity 100 % Genes 34 %
LPL. By Division Human Genetics Medical University Innsbruck in Austria. LPL Specificity 100 % Genes 34 %
Lipoprotein lipase deficiency: LPL gene mutation analysis (G188E). By GENETAQ Molecular Genetics Centre and Diagnosis of Rare Diseases in Spain. LPL Specificity 100 % Genes 34 %
Lipoprotein lipase deficiency: LPL gene regulatory region sequence analysis. By GENETAQ Molecular Genetics Centre and Diagnosis of Rare Diseases in Spain. LPL Specificity 100 % Genes 34 %
Lipoprotein lipase deficiency: LPL gene sequence analysis. By GENETAQ Molecular Genetics Centre and Diagnosis of Rare Diseases in Spain. LPL Specificity 100 % Genes 34 %
Major Hypertriglyceridemia: sequencing of LPL gene. By GENETAQ Molecular Genetics Centre and Diagnosis of Rare Diseases in Spain. LPL Specificity 100 % Genes 34 %
LPL. By Fulgent Genetics Fulgent Genetics in United States. LPL Specificity 100 % Genes 34 %
Familial lipoprotein lipase deficiency. By Bioarray in Spain. LPL Specificity 100 % Genes 34 %
Familial lipoprotein lipase deficiency. By Bioarray in Spain. LPL Specificity 100 % Genes 34 %
CarrierMap. By Recombine in United States. FMR1, MTHFR, MCCC1, MCCC2, ABCB11, ACADM, ACADS, AGL, ACADVL, ACAT1, ALDOB, PC, USH1C, ALPL, ARG1, HLCS, ATP7A, BTD, ATP7B, BCKDHA , (...) View the complete list with 281 more genes Panel GTR000528277 complete gene list FMR1, MTHFR, MCCC1, MCCC2, ABCB11, ACADM, ACADS, AGL, ACADVL, ACAT1, ALDOB, PC, USH1C, ALPL, ARG1, HLCS, ATP7A, BTD, ATP7B, BCKDHA, BCKDHB, BCS1L, GAA, HBB, MMACHC, TYRP1, STAR, SLC45A2, CHM, TYR, SLC37A4, ABCA12, HSD17B4, CPT2, TRMU, GNPTAB, GLB1, GNE, OCRL, ABCA4, CYP1B1, CEP290, CLRN1, TRIM32, USH2A, PCDH15, DLD, POLG, CYP11B1, SLC25A13, HADHA, OPA3, FH, RPE65, RLBP1, GUCY2D, SMPD1, CYP11B2, SLC26A4, CDH23, HPS1, PDHB, HPS4, HPS3, DHDDS, RS1, FAH, HMGCL, HSD3B2, FAM161A, TAT, G6PC, GAMT, RDH12, RARS2, HAX1, HADHB, CERKL, PCCB, PCCA, GLDC, AMT, LCA5, ALG6, TYMP, MPI, ETHE1, MYO7A, PUS1, OTC, PDHA1, ABCD1, HEXA, ALDH3A2, HEXB, CTSK, ACOX1, PTS, PAH, AGXT, TCIRG1, MPV17, CPT1A, GUSB, GALNS, GNS, HGSNAT, NAGLU, SGSH, NDUFS6, MMAB, MMAA, MUT, DBT, MAN2B1, MLYCD, GALC, IVD, SLC25A15, CBS, CYBA, PFKM, PYGM, GBE1, ETFB, ETFA, ETFDH, GCDH, GALT, GALK1, LRPPRC, SLC3A1, ASS1, CYP27A1, SLC22A5, SLC25A20, PMM2, BBS12, MKS1, BBS10, BBS1, BBS2, ASL, TPP1, CYP17A1, NR2E3, ADA, AGA, ARSB, IL2RG, AIRE, AR, ARSA, ASPA, ELP1, CFTR, FANCC, GBA, BLM, DHCR7, DMD, GJB2, GLA, IDS, IDUA, LIPA, NPC1, NPC2, RMRP, SMN1, ATM, NBN, BRIP1, ADAMTS2, CHRNE, CLN6, CLN8, COL4A3, DOK7, HBA1, LAMB3, FKTN, MTTP, G6PD, HBA2, NEB, CTNS, CYBB, PEX2, NPHS2, PROP1, NPHS1, DCLRE1C, PPT1, PEX7, SGCA, SGCB, SERPINA1, SLC7A7, SACS, SLC26A2, SLC35A3, UGT1A1, TH, GRHPR, LAMA3, MLC1, MCOLN1, MPL, PEX1, POMGNT1, RTEL1, SGCG, SLC12A6, SLC17A5, SUMF1, TTPA, WAS, ABCC8, CAPN3, CLN5, EIF2B5, LAMC2, PHGDH, PKHD1, RAPSN, TGM1, TMEM216, GJB1, NTRK1, FKRP, DYSF, LHCGR, KCNJ11, CYP21A2, COL4A4, SLC12A3, BSND, COL4A5, MTM1, VRK1, EMD, SGCD, TSEN54, MFSD8, VPS13B, VPS13A, ATP6V1B1, MYO15A, SLC4A11, PRPS1, PEX6, LOXHD1, PEX10, CHRNG, RAB23, POR, EXOSC3, CTSC, LYST, DNAI2, DNAI1, ERCC6, TECPR2, MEFV, SRD5A2, F9, F8, FANCA, FANCG, EVC, EVC2, LPL, EIF2AK3, VSX2, RAG2, ERCC8, SLC39A4, COL7A1, CIITA, EDA, TTC37, TFR2, HOGA1, HJV, CYP19A1, AMH, AMHR2, ASNS, MED17, SEPSECS, WRN, XPA, LIFR, SLC7A9, XPC, GDF5, HGD, BCHE, SLC26A3, VPS53 Specificity 1 % Genes 34 %
HYPERLIPOPROTEINEMIA TYPE 1. By Laboratorio de Genetica Clinica SL in Spain. LPL, LMF1, APOC2, GPIHBP1 Specificity 25 % Genes 34 %
Major Hypertriglyceridemia, Sequencing LPL Gene. By Reference Laboratory Genetics in Spain. LPL Specificity 100 % Genes 34 %
Lipoprotein Lipase Deficiency , Sequencing Regulatory Area LPL Gene. By Reference Laboratory Genetics in Spain. LPL Specificity 100 % Genes 34 %
Major Hypertriglyceridemia, Deletions-Duplications (MLPA) LPL Gene. By Reference Laboratory Genetics in Spain. LPL Specificity 100 % Genes 34 %

Alternate names

Hyperlipoproteinemia, Type V Is also known as hyperlipidemia, type v, hyperchylomicronemia, late-onset, hyperchylomicronemia with hyperprebetalipoproteinemia, familial, hyperlipemia, mixed, hyperlipemia, combined fat and carbohydrate-induced;hlp type 5; major hyperlipidemia.

If you liked this article maybe you will also find interesting the following in-depth articles about other rare diseases, like MYOPATHY DUE TO MYOADENYLATE DEAMINASE DEFICIENCY; MMDD NEURODEVELOPMENTAL DISORDER WITH EPILEPSY, CATARACTS, FEEDING DIFFICULTIES, AND DELAYED BRAIN MYELINATION; NECFM MICROSPHEROPHAKIA AND/OR MEGALOCORNEA, WITH ECTOPIA LENTIS AND WITH OR WITHOUT SECONDARY GLAUCOMA; MSPKA